82 related articles for article (PubMed ID: 23246116)
21. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
Sacca R; Cuff CA; Lesslauer W; Ruddle NH
J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
[TBL] [Abstract][Full Text] [Related]
22. Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1.
Etemadi N; Webb A; Bankovacki A; Silke J; Nachbur U
Immunol Cell Biol; 2013; 91(10):661-4. PubMed ID: 24100384
[TBL] [Abstract][Full Text] [Related]
23. Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1.
Lukić IK; Grcević D; Kovacić N; Katavić V; Ivcević S; Kalajzić I; Marusić A
Clin Exp Immunol; 2005 Feb; 139(2):236-44. PubMed ID: 15654822
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-binding protein-5 (IGFBP-5) inhibits TNF-α-induced NF-κB activity by binding to TNFR1.
Hwang JR; Huh JH; Lee Y; Lee SI; Rho SB; Lee JH
Biochem Biophys Res Commun; 2011 Feb; 405(4):545-51. PubMed ID: 21256825
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.
Amar S; Van Dyke TE; Eugster HP; Schultze N; Koebel P; Bluethmann H
J Inflamm; 1995-1996; 47(4):180-9. PubMed ID: 9144075
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.
Chuang HC; Lay JD; Chuang SE; Hsieh WC; Chang Y; Su IJ
Am J Pathol; 2007 May; 170(5):1607-17. PubMed ID: 17456766
[TBL] [Abstract][Full Text] [Related]
27. Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window.
Shibata H; Yoshioka Y; Ikemizu S; Kobayashi K; Yamamoto Y; Mukai Y; Okamoto T; Taniai M; Kawamura M; Abe Y; Nakagawa S; Hayakawa T; Nagata S; Yamagata Y; Mayumi T; Kamada H; Tsutsumi Y
Clin Cancer Res; 2004 Dec; 10(24):8293-300. PubMed ID: 15623605
[TBL] [Abstract][Full Text] [Related]
28. Astrocyte reactivity to unconjugated bilirubin requires TNF-α and IL-1β receptor signaling pathways.
Fernandes A; Barateiro A; Falcão AS; Silva SL; Vaz AR; Brito MA; Silva RF; Brites D
Glia; 2011 Jan; 59(1):14-25. PubMed ID: 20967881
[TBL] [Abstract][Full Text] [Related]
29. Creation of a lysine-deficient LIGHT mutant with the capacity for site-specific PEGylation and low affinity for a decoy receptor.
Morishige T; Yoshioka Y; Inakura H; Tanabe A; Yao X; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
Biochem Biophys Res Commun; 2010 Mar; 393(4):888-93. PubMed ID: 20175993
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice.
Nomura T; Abe Y; Kamada H; Shibata H; Kayamuro H; Inoue M; Kawara T; Arita S; Furuya T; Yamashita T; Nagano K; Yoshikawa T; Yoshioka Y; Mukai Y; Nakagawa S; Taniai M; Ohta T; Serada S; Naka T; Tsunoda S; Tsutsumi Y
J Control Release; 2011 Jan; 149(1):8-14. PubMed ID: 20036293
[TBL] [Abstract][Full Text] [Related]
31. Troy binding to lymphotoxin-alpha activates NF kappa B mediated transcription.
Hashimoto T; Schlessinger D; Cui CY
Cell Cycle; 2008 Jan; 7(1):106-11. PubMed ID: 18202551
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
33. Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain.
Geis C; Graulich M; Wissmann A; Hagenacker T; Thomale J; Sommer C; Schäfers M
Neuroscience; 2010 Aug; 169(1):463-74. PubMed ID: 20417692
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor receptor cross-talk.
Naudé PJ; den Boer JA; Luiten PG; Eisel UL
FEBS J; 2011 Apr; 278(6):888-98. PubMed ID: 21232019
[TBL] [Abstract][Full Text] [Related]
35. TNF-alpha induces matrix metalloproteinase-9 expression in A549 cells: role of TNFR1/TRAF2/PKCalpha-dependent signaling pathways.
Lee IT; Lin CC; Wu YC; Yang CM
J Cell Physiol; 2010 Aug; 224(2):454-64. PubMed ID: 20333651
[TBL] [Abstract][Full Text] [Related]
36. Platinums sensitize human epithelial tumor cells to lymphotoxin alpha by inhibiting NFkappaB-dependent transcription.
Shen Y; Wang J; Yang T; Li Y; Jiang W; Guan Z; Wang Z; Tan J; Wu J; Li G; Xu Q; Wu F; Wang L; Liu Y
Cancer Biol Ther; 2008 Sep; 7(9):1407-14. PubMed ID: 18719365
[TBL] [Abstract][Full Text] [Related]
37. Lymphotoxin-alpha and cardiovascular disease: clinical association and pathogenic mechanisms.
Naoum JJ; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
Med Sci Monit; 2006 Jul; 12(7):RA121-4. PubMed ID: 16810143
[TBL] [Abstract][Full Text] [Related]
38. Are different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?
Mascarenhas NM; Kästner J
BMC Struct Biol; 2012 May; 12():8. PubMed ID: 22568977
[TBL] [Abstract][Full Text] [Related]
39. The lymphotoxin-alpha (LTalpha) subunit is essential for the assembly, but not for the receptor specificity, of the membrane-anchored LTalpha1beta2 heterotrimeric ligand.
Williams-Abbott L; Walter BN; Cheung TC; Goh CR; Porter AG; Ware CF
J Biol Chem; 1997 Aug; 272(31):19451-6. PubMed ID: 9235946
[TBL] [Abstract][Full Text] [Related]
40. Creation of mouse TNFR2-selective agonistic TNF mutants using a phage display technique.
Ando D; Inoue M; Kamada H; Taki S; Furuya T; Abe Y; Nagano K; Tsutsumi Y; Tsunoda SI
Biochem Biophys Rep; 2016 Sep; 7():309-315. PubMed ID: 28955920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
